Green Thumb Industries has been growing earnings at an average annual rate of 5.9%, while the Pharmaceuticals industry saw earnings growing at 10.7% annually. Revenues have been growing at an average rate of 8.5% per year. Green Thumb Industries's return on equity is 6.5%, and it has net margins of 10.1%.
Key information
5.90%
Earnings growth rate
4.31%
EPS growth rate
Pharmaceuticals Industry Growth
5.95%
Revenue growth rate
8.48%
Return on equity
6.47%
Net Margin
10.14%
Next Earnings Update
04 Aug 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Green Thumb Industries makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:GTBI.F Revenue, expenses and earnings (USD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
1,196
121
439
0
31 Dec 25
1,175
114
437
0
30 Sep 25
1,158
44
415
0
30 Jun 25
1,154
29
413
0
31 Mar 25
1,141
50
403
0
31 Dec 24
1,137
73
376
0
30 Sep 24
1,121
64
366
0
30 Jun 24
1,110
66
342
0
31 Mar 24
1,082
58
330
0
31 Dec 23
1,055
36
336
0
30 Sep 23
1,036
-18
325
0
30 Jun 23
1,021
-19
326
0
31 Mar 23
1,023
-8
305
0
31 Dec 22
1,017
12
293
0
30 Sep 22
1,002
86
282
0
30 Jun 22
974
96
271
0
31 Mar 22
942
94
279
0
31 Dec 21
894
75
272
0
30 Sep 21
827
75
256
0
30 Jun 21
751
65
234
0
31 Mar 21
648
30
212
0
31 Dec 20
557
15
198
0
30 Sep 20
455
-22
191
0
30 Jun 20
366
-46
172
0
31 Mar 20
291
-54
153
0
31 Dec 19
216
-59
135
0
30 Sep 19
161
-46
112
0
30 Jun 19
111
-35
91
0
31 Mar 19
79
-13
72
0
31 Dec 18
62
-5
52
0
30 Sep 18
48
-7
32
0
30 Jun 18
35
-5
24
0
31 Mar 18
24
-7
15
0
31 Dec 17
17
-4
11
0
31 Dec 16
7
-3
5
0
Quality Earnings: GTBI.F has high quality earnings.
Growing Profit Margin: GTBI.F's current net profit margins (10.1%) are higher than last year (4.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GTBI.F's earnings have grown by 5.9% per year over the past 5 years.
Accelerating Growth: GTBI.F's earnings growth over the past year (141%) exceeds its 5-year average (5.9% per year).
Earnings vs Industry: GTBI.F earnings growth over the past year (141%) exceeded the Pharmaceuticals industry -6%.
Return on Equity
High ROE: GTBI.F's Return on Equity (6.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/21 22:09
End of Day Share Price
2026/07/21 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Green Thumb Industries Inc. is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.